跳至主要内容
临床试验/ISRCTN11416813
ISRCTN11416813已完成未知

Effectiveness of homeopathic treatment (Agraphis nutans 5CH, Thuya occidentalis 5CH, Kalium muriaticum 9CH and Arsenicum iodatum 9CH), as an adjuvant in secretory otitis (SO) in childhood: a randomized parallel double-blind clinical trial

Individual sponsor (Spain)0 个研究点目标入组 220 人开始时间: 2013年2月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age: 2 months - 12 years
  • 2. Informed consent from parents and / or tutors
  • 3. SO diagnosed unilateral or bilateral diagnosed in otolaryngology consultations with pneumatic otoscopy, according to the presence or absence of tympanic mobility. Each ear counted as one unit of primary endpoint.
  • 4. Do not be following any regular treatment, specifically especially corticosteroids, antihistamines and mucolytics

排除标准

  • 1. Acute Otitis Media or complicated at the time of baseline
  • 2. Have not passed the newborn hearing screenig (OAE)
  • 3. Concomitant diseases
  • 4. Permanent sensorineural hearing loss
  • 6. Down Syndrome craneofaciales or other malformations
  • 7. Malformations of the outer or middle ear
  • 8. Acute Mastoiditis or Cholesteatoma
  • 9. Recent vaccination (less than 30 days)
  • 10. Cilial motility disorders (Kartagener syndrome)
  • 11. Alterations prelingual speech or language
  • 12. Obstructive sleep apnea (OSA)
  • 13. Adenoidectomy
  • 14. Persistence of Tubo-tympanic disease (TTD) or perforated eardrum
  • 15. Lactose intolerance or diabetes (incompatible with placebo and homeopathy)

研究者

发起方
Individual sponsor (Spain)

相似试验